233 results
8-K
EX-99.1
TEVA
Teva- Pharmaceutical Industries Ltd.
15 May 24
Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations
8:30am
journey.”
Mr. Francis added: “As we have intensified our efforts to best position Teva for future success through our Pivot to Growth strategy, Eric Drapé … potential based on the early progress of its Pivot to Growth strategy, and its tremendous heritage in manufacturing important medicines serving
8-K
EX-99.1
TEVA
Teva- Pharmaceutical Industries Ltd.
8 May 24
Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook
7:01am
continued, “As we mark the first anniversary of our Pivot to Growth Strategy, I am proud of the significant strides we have been making in realizing … .
As we continue to accelerate our growth progress, we reaffirm our financial guidance for 2024.”
Pivot to Growth Strategy
In May 2023, we introduced
8-K
TEVA
Teva- Pharmaceutical Industries Ltd.
18 Apr 24
Regulation FD Disclosure
4:06pm
shift in executive management responsibilities and in alignment with Teva’s Pivot to Growth strategy, Teva decided that Canada will no longer
8-K
EX-99.1
y6k dht6tw
31 Jan 24
Results of Operations and Financial Condition
7:00am
8-K
EX-99.1
i22x4rsl5ggy77hi91mb
8 Nov 23
2023 revenues outlook revised to $15.1 - $15.5 billion from $15.0 - $15.4 billion
7:01am
8-K
m0ziryprom pa
4 Oct 23
Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatment
6:05am
8-K
EX-99.1
5fykvt 0xa112rc5wfw
4 Oct 23
Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatment
6:05am
8-K
EX-99.1
hxgunjrbhzf0jd9pe29
2 Aug 23
Results of Operations and Financial Condition
7:00am
SD
EX-1.01
kdbrx4wb
24 May 23
Conflict minerals disclosure
12:00am
8-K
EX-99.1
5nj3iavpd1ah3zcn
10 May 23
Results of Operations and Financial Condition
7:01am
8-K
EX-99.1
rmqt4stagz8wob
21 Nov 22
Teva Announces Appointment of Richard Francis as President and CEO
7:00am